Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever. Lassa fever is lethal in humans and ...
GALVESTON, TEXAS -- In a new study, researchers at the University of Texas Medical Branch show that a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever, provides rapid ...
Researchers report the results of the first ever genome-wide association study (GWAS) of a biosafety level 4 (BSL-4) virus. The team found two key human genetic factors that could help explain why ...
Patients were taken to the canteen of a hospital in Bangkok. — © AFP Montira RUNGJIRAJITTRANON Patients were taken to the canteen of a hospital in Bangkok ...
Please provide your email address to receive an email when new articles are posted on . CEPI is funding a $14.9 million project to develop Nipah virus and Lassa fever rapid tests to better identify ...
NEW YORK--(BUSINESS WIRE)--IAVI, a nonprofit scientific research organization, announces that volunteers at the PREVAIL clinical trial site at Redemption Hospital (RH 1) in Monrovia, Liberia, have ...
A single-dose vaccine offers fast protection against illness caused by the dangerous pathogen Lassa virus, according to research in monkeys 1. Lassa virus infects hundreds of thousands of people ...
A case of Lassa fever has been reported in Paris, France, sparking lurid warnings about the “horrific Ebola-like bug”. As the name suggests, Lassa fever causes a high temperature, but also weakness, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results